Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Shandong Xinhua Pharmaceutical Company Limited Class H ( (HK:0719) ) has shared an update.
Shandong Xinhua Pharmaceutical Company Limited has announced a board meeting scheduled for October 24, 2025, to review and approve the unaudited financial results for the nine months ending September 30, 2025. This meeting is significant for stakeholders as it will provide insights into the company’s financial performance and potential strategic directions.
More about Shandong Xinhua Pharmaceutical Company Limited Class H
Shandong Xinhua Pharmaceutical Company Limited is a joint stock company based in the People’s Republic of China, primarily operating in the pharmaceutical industry. The company focuses on the production and distribution of pharmaceutical products.
Average Trading Volume: 6,549,300
Technical Sentiment Signal: Buy
Current Market Cap: HK$9.78B
Learn more about 0719 stock on TipRanks’ Stock Analysis page.